Cubist Pharmaceuticals
(NASDAQ: CBST)
+1.16
+2.32%
Cubist Pharmaceuticals, a mid-cap growth company in the health care sector, is expected to outperform the market over the next six months with less than average risk.
10 is the best possible rating.
The StockScouter measure of relative price change and consistency is very high. Very positive
Earnings growth in the past year has accelerated rapidly compared to earnings growth in the past three years. Positive
ConThe most recent quarterly earnings report was significantly lower than analysts' consensus forecast. Negative
The price-to-earnings multiple is higher than the average for all stocks in the StockScouter universe. Negative
The most recent quarterly earnings report was significantly lower than analysts' consensus forecast. Negative
Earnings growth in the past year has accelerated rapidly compared to earnings growth in the past three years. Positive
One or more analysts has modestly decreased quarterly earnings estimates for CBST. Negative
An executive, director or major shareholder sold a small number of shares recently. Neutral
Shares are neither being accumulated heavily nor sold heavily by financial institutions. Neutral for a large company like CBST
The price-to-earnings multiple is higher than the average for all stocks in the StockScouter universe. Negative
The price-to-sales multiple is slightly higher than the average for all stocks in the StockScouter universe. Positive/Neutral for a medium- to large-sized company like CBST
The ratio of CBST's price-to-earnings multiple to its five-year growth rate is above the average of all stocks in the StockScouter universe. Negative
The StockScouter measure of relative price change and consistency is very high. Very positive
Previous day's closing price for CBST was close to its 50-day moving average. Neutral
data provided by Verus Analytics
Learn more about the StockScouter rating system.
Page generated 6/19/2013 7:18 AM ET
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
